Latest AI and machine learning research in diabetes for healthcare professionals.
In routine care, individuals identified a priori as high-risk are usually tested for conditions more frequently. Protected attributes, such as sex or ethnicity may also determine testing frequency. Such heterogeneous detection rates across a population induce label error. This causes systematic model error for specific groups and biases performance metrics during validation. This paper proposes ...
Diabetic Retinopathy (DR) is a leading cause of preventable blindness among working-age adults worldwide, yet most automated screening systems are limited to image-level classification and lack clinically structured reporting. We propose Retina-RAG, a low-cost modular framework that jointly performs DR severity grading, macular edema (ME) detection, and report generation. The architecture decouple...
Medication adherence among patients with diabetes remains suboptimal in low and middle income countries, including Nigeria. Emerging digital health in...
Neuroectoderm-derived tissues are highly metabolically active and exhibit minimal regenerative turnover, rendering them uniquely vulnerable to age-rel...
Disease is a heterogeneous process that involves multiple organs and cell types. Understanding how genomic variation contributes to disease requires a...
The advent of foundation models has heralded a new era in medical artificial intelligence (AI), enabling the extraction of generalizable representatio...
We present a digital twin framework for real time glucose monitoring and forecasting in septic patients in intensive care units (ICUs). The framework ...
Excessive alcohol consumption remains a major public health challenge with limited therapeutic options. Both glucagon-like peptide-1 (GLP-1) and fibro...
Clinical time-series forecasting is increasingly studied for decision support, yet standard aggregate metrics can obscure whether a model is actually ...
The systemic, metabolic, lifestyle factors have established associations with Alzheimer's Disease (AD) through epidemiologic and AD-specific biomarker...
Background: Electronic health records (EHRs) with clinical decision support tools are now ubiquitous in healthcare organizations. Clinical foundation ...
Retinal fluids, detectable through optical coherence tomography (OCT), are key biomarkers for retinal diseases such as diabetic macular edema and age-...
Background: Diabetic retinopathy (DR) is the leading cause of preventable blindness among working-age adults worldwide, yet screening coverage remains...
Objective To develop and evaluate a novel machine learning (ML) framework tailored to a clinical diabetes dataset and to assess whether demographic st...
Artificial Intelligence and Machine Learning (AI/ML) models used in clinical settings are increasingly deployed to support clinical decision-making. H...
Disease progression varies with age and is influenced by underlying genetic, biochemical, and hormonal etiologies, suggesting the need for tailored mo...
Metabolic dysfunction is increasingly recognized as a risk factor for poor outcomes in breast cancer, but whether incretin-based therapies confer surv...
Multimodal learning has the potential to improve clinical prediction by integrating complementary data sources, but the incremental value of imaging b...
Introduction: Accurate stratification of hard atherosclerotic cardiovascular disease (ASCVD) risk remains challenging despite advances in prevention. ...
Diabetic retinopathy (DR) is a leading cause of vision impairment worldwide, and automated grading systems play a crucial role in large-scale screenin...